Showing results (131-140 of 283) with videos related to

Sort By:
Pageof 29
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|January 7, 2022
Quality of training in cervical cancer radical surgery: a survey from the European Network of Young Gynaecologic Oncologists (ENYGO)Nicolò Bizzarri, Andrei Pletnev, Zoia Razumova, et al.
The Lancet. Oncology|July 14, 2019
Association between the cervicovaginal microbiome, BRCA1 mutation status, and risk of ovarian cancer: a case-control studyNuno R Nené, Daniel Reisel, Andreas Leimbach, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|October 5, 2021
Randomized phase III trial on niraparib-TSR-042 (dostarlimab) versus physician's choice chemotherapy in recurrent ovarian, fallopian tube, or primary peritoneal cancer patients not candidate for platinum retreatment: NItCHE trial (MITO 33)Lucia Musacchio, Vanda Salutari, Sandro Pignata, et al.
Annals of Surgical Oncology|October 12, 2012
Value of tertiary cytoreductive surgery in epithelial ovarian cancer: an international multicenter evaluationChristina Fotopoulou, Rongyu Zang, Murat Gultekin, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|August 31, 2023
MILACC study: could undetected lymph node micrometastases have impacted recurrence rate in the LACC trial?Roni Nitecki, Pedro T Ramirez, Pavel Dundr, et al.
Genome Medicine|December 23, 2017
The potential of circulating tumor DNA methylation analysis for the early detection and management of ovarian cancerMartin Widschwendter, Michal Zikan, Benjamin Wahl, et al.
Clinical Epigenetics|November 22, 2022
DNA methylation-based detection and prediction of cervical intraepithelial neoplasia grade 3 and invasive cervical cancer with the WID™-qCIN testChiara Herzog, Karin Sundström, Allison Jones, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|January 5, 2020
European Society of Gynaecological Oncology quality indicators for surgical treatment of cervical cancerDavid Cibula, François Planchamp, Daniela Fischerova, et al.
Genome Biology|February 22, 2022
Susceptibility to hormone-mediated cancer is reflected by different tick rates of the epithelial and general epigenetic clockJames E Barrett, Chiara Herzog, Yoo-Na Kim, et al.
Future Oncology (London, England)|July 31, 2024
Maintenance with mirvetuximab soravtansine plus bevacizumab vs bevacizumab in FRα-high platinum-sensitive ovarian cancerDavid M O'Malley, Tashanna Myers, Pauline Wimberger, et al.
Pageof 29